Biotech · Private company · Fremont, CA, US
Sansimeon, Inc
Track this companyFree. Adds Sansimeon, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards4
- A Fully Integrated Platform for Reproducible and Scalable Single-Cell Sequencing in Clinical ResearchFiscal year 2026 · $382.8KNIH RePORTER 1R44GM163418-01 · fetched Nov 12, 2026
- A Uniquely Scalable Platform for Sequencing Tens of Millions of Single Cells from Complex Clinical Samples with a Streamlined WorkflowFiscal year 2026 · $1.1MNIH RePORTER 5R44GM149003-03 · fetched Nov 12, 2026
- A Uniquely Scalable Platform for Sequencing Tens of Millions of Single Cells from Complex Clinical Samples with a Streamlined WorkflowFiscal year 2025 · $938.3KNIH RePORTER 2R44GM149003-02 · fetched Nov 12, 2026
- A Uniquely Scalable Approach to Single Cell Sequencing for the Development of Next Generation Cell TherapiesFiscal year 2024 · $399.4KNIH RePORTER 1R43HG013446-01 · fetched Nov 12, 2026